Familial Hypercholesterolemia Tied to Significantly Increased CVD Risk

Share this content:
Familial hypercholesterolemia is associated with an increased risk for CHD and ASCVD.
Familial hypercholesterolemia is associated with an increased risk for CHD and ASCVD.

(HealthDay News) — Patients with heterozygous familial hypercholesterolemia (FH) have a significantly increased risk for coronary heart disease (CHD) and atherosclerotic cardiovascular disease (ASCVD), according to research published in Circulation.

The researchers reviewed data from 6 groups of individuals involved in previous studies. Compared with participants with average LDL cholesterol levels (<130 mg/dL), those with FH had a 5 times higher risk for CHD.

Those with FH were also more likely to have ASCVD up to 20 years earlier in men and 30 years earlier in women. Even when the researchers included other risk factors for cardiovascular disease in their analysis, the risks were still higher for those with FH.

"In the general US population, the long-term ASCVD burden related to phenotypic FH, defined by LDL cholesterol ≥190 mg/dL, is likely substantial," the researchers wrote. "Our finding of CHD risk acceleration may aid efforts in risk communication."

Reference

  1. Perak AM, Ning H, de Ferranti SD, Gooding HC, Wilkins JT, Lloyd-Jones DM. Long-Term Risk of Atherosclerotic Cardiovascular Disease in US Adults With the Familial Hypercholesterolemia Phenotype. Circulation. 2016. doi:10.1161/CIRCULATIONAHA.116.022335.
You must be a registered member of Endocrinology Advisor to post a comment.

Sign Up for Free e-Newsletters

CME Focus